Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1

Clinical trial NCT04860960 · UNKNOWN

Trial details

NCT number: NCT04860960
Sponsor: Cyclo Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Niemann-Pick Disease, Type C1

Start date: 2021-07-20
Primary completion: 2025-06-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.